Literature DB >> 3581092

Re: Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function.

R G Fish, M D Shelley, H Griffiths, M Adams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3581092

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  4 in total

Review 1.  Clinical pharmacokinetics and dose optimisation of carboplatin.

Authors:  S B Duffull; B A Robinson
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of carboplatin.

Authors:  W J van der Vijgh
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

3.  Dose-toxicity relationship of carboplatin in combination with cyclophosphamide in ovarian cancer patients.

Authors:  B T Sørensen; A Strömgren; P Jakobsen; A Jakobsen
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

4.  Acute and cumulative effects of carboplatin on renal function.

Authors:  D T Sleijfer; E F Smit; S Meijer; N H Mulder; P E Postmus
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.